TABLE 1.
Demographic characteristics of the clinical trial (TU) and observational (OBS) study cohorts.
| DIAN-TU |
DIAN Obs |
|||||
| NMC | MC CDR 0 | MC CDR > 0 | NMC | MC CDR 0 | MC CDR > 0 | |
| N | 46 | 85 | 59 | 115 | 35 | 34 |
| Age | 42.0 (9.2) | 40.9 (8.5) | 49.2 (10.1) | 41.3 (8.9) | 38.7 (9.5) | 46.0 (8.3) |
| EYO | –4.5 (6.3) | –5.8 (6.3) | 2.7 (4.8) | –6.1 (6.8) | –8.3 (6.0) | 1.2 (3.9) |
| Sex (% female) | 20 (43%) | 45 (53%) | 28 (47%) | 70 (61%) | 25 (71%) | 22 (65%) |
| Education | 15.5 (3.2) | 15.6 (3.2) | 14.1 (2.6) | 14.9 (2.8) | 14.3 (2.7) | 13.2 (3.2) |
| Number of assessments | 7.3 (3.6) | 9.5 (2.2) | 8.1 (2.5) | 2.2 (1.3) | 2.7 (1.1) | 3.3 (1.2) |
| Length of follow-up | 3.1 (1.8) | 4.2 (1.1) | 3.6 (1.3) | 2.5 (2.5) | 3.6 (1.9) | 2.9 (1.6) |
Results are reported as mean (SD) where appropriate.